Markets:

Overview

News

Currencies

International

Treasuries

Abbott Laboratories (NY:ABT)

130.59 +1.33 (+1.03%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

50 51 Next >

Biotech Stocks Stay Strong Through A Period Of Uncertainty In The Market ↗

February 24, 2025

Many analysts are feeling better about the prospects for healthcare stocks in 2025.

Via Talk Markets

Topics ETFs Stocks / Equities

Q4 Earnings Highs And Lows: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks

February 24, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers.

Via StockStory

Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom ↗

February 14, 2025

DexCom reported Q4 revenue of $1.11 billion, surpassing estimates. The company reaffirmed its 2025 outlook while analysts highlighted long-term growth potential.

Via Benzinga

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever. ↗

February 13, 2025

Via The Motley Fool

Rep. Emily Randall Has Sold Up to $165K Worth Of Abbott Laboratories Stock: Here's What You Should Know ↗

February 12, 2025

Via Benzinga

Looking Into Abbott Laboratories's Recent Short Interest ↗

February 11, 2025

Via Benzinga

This Is What Whales Are Betting On Abbott Laboratories ↗

January 27, 2025

Via Benzinga

Market Whales and Their Recent Bets on ABT Options ↗

January 24, 2025

Via Benzinga

3 No-Brainer Healthcare Stocks to Buy With $200 Right Now ↗

February 10, 2025

Via The Motley Fool

Q4 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Boston Scientific (NYSE:BSX)

February 10, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Scientific (NYSE:BSX) and the best...

Via StockStory

3 Fabulous Dividend Stocks to Buy in February ↗

February 09, 2025

Via The Motley Fool

3 Dividend Growth Stocks For Intergenerational Wealth ↗

February 06, 2025

Long-term investors can create intergenerational wealth with dividend growth investing.

Via Talk Markets

Topics Stocks / Equities

2 Unstoppable Dividend Stocks That Will Pay You for Life ↗

February 03, 2025

Via The Motley Fool

Deep Dive Into Abbott Laboratories Stock: Analyst Perspectives (6 Ratings) ↗

January 23, 2025

Via Benzinga

AbbVie (NYSE:ABBV) Posts Better-Than-Expected Sales In Q4, Stock Soars

January 31, 2025

Pharmaceutical company AbbVie (NYSE:ABBV) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 5.6% year on year to $15.1 billion. Its non-GAAP profit of $2.16 per share...

Via StockStory

Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates

January 31, 2025

Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 7.2% year on year to $10.97 billion. Its non-GAAP profit of $1.34...

Via StockStory

9 Health Care Stocks With Whale Alerts In Today's Session ↗

January 28, 2025

Via Benzinga

Jim Cramer Is Worried About This Consumer Cyclical Stock: 7% Yield? 'Something May Be Wrong Here' ↗

January 27, 2025

Cramer takes a look at TETRA Technologies, Abbott, Wendy's, Nu Holdings and Casella Waste on the latest edition of "Mad Money."

Via Benzinga

Abbott To Rally Over 26%? Here Are 10 Top Analyst Forecasts For Monday ↗

January 27, 2025

Via Benzinga

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

January 24, 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

Via MarketBeat

Why Is Abbott Stock Trading Higher On Thursday? ↗

January 23, 2025

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes Care and Medical Devices.

Via Benzinga

Congressional Trading Report: Rep. Thomas Kean Bought Over $1K In Abbott Laboratories Stock ↗

January 23, 2025

Via Benzinga

US Stock Futures Trade Mixed After Skirting Record Highs In Last Session: GE Aerospace, American Airlines, Union Pacific In Focus ↗

January 23, 2025

U.S. stock futures were mixed on Thursday following Wednesday's rally. Futures of benchmark indices were lower except Dow Jones.

Via Benzinga

Topics Stocks

My Top 5 Stocks to Buy in Early 2025 ↗

January 23, 2025

Via The Motley Fool

S&P 500 Hits New Record As Netflix Reports Strong Results: Investor Sentiment Improves But Greed Index Remains In 'Fear' Zone ↗

January 23, 2025

Via Benzinga

Topics Stocks

S&P 500 Hits Fresh Records At 6,100: Strong Earnings, Trump's AI Wager Fuel Bull Run ↗

January 22, 2025

Market surges on AI Stargate initiative & strong earnings. S&P 500 hits record high of 6,100 points, led by tech giants & semiconductor stocks.

Via Benzinga

Topics Artificial Intelligence Government Stocks

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales ↗

January 22, 2025

Via Benzinga

Abbott Laboratories (ABT) Q4 2024 Earnings Call Transcript ↗

January 22, 2025

ABT earnings call for the period ending December 31, 2024.

Via The Motley Fool

Topics Earnings

Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday? ↗

January 22, 2025

Tech stocks enjoyed a surge Wednesday, driven by a sharp rise in semiconductor shares after President Donald Trump, OpenAI's Sam Altman, Oracle Corp.

Via Benzinga

Topics Artificial Intelligence Government

Abbott Labs Q4 Earnings And Q1 Profit Guidance Lags Street View, Worldwide COVID-19 Testing Sales Fall ↗

January 22, 2025

Abbott's Q4 sales reached $10.97 billion, with 8.8% organic growth. EPS met expectations at $1.34, driven by strong performance in medical devices.

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

50 51 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Abbott Laboratories (NY:ABT)

All News about Abbott Laboratories

Starting at $3.75/week.

Subscribe Today